Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-08-20
DOI
https://doi.org/10.3324/haematol.2026.300987
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Jingshi Wang, Yubo Pi, Wenqing Li, Zhao Wang et al.
Haematologica
Autoimmune and Inflammatory Disorders Research
article

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Jingshi Wang, Yubo Pi, Wenqing Li, Zhao Wang, Lin Shi, Mei Wang, Yu Li
article en

Abstract

No abstract available for this paper.
Haematologica
Shanghai Liangyou (China) (CN), Beijing Friendship Hospital (CN)
National Natural Science Foundation of China
Zero hunger
Openalex Percentile: Top 10%
Autoimmune and Inflammatory Disorders Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.